| Kalamazoo Oral & Maxillofacial Surgery, P.c. | |
|
3801 Glenkerry Ct Portage MI 49024-0718 | |
| (269) 323-1527 | |
| (269) 323-1670 |
| Full Name | Kalamazoo Oral & Maxillofacial Surgery, P.c. |
|---|---|
| Speciality | Dentist |
| Location | 3801 Glenkerry Ct, Portage, Michigan |
| Authorized Official Name and Position | Nancy Simonelli (OFFICE MANAGER) |
| Authorized Official Contact | 2693231527 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Kalamazoo Oral & Maxillofacial Surgery, P.c. 3801 Glenkerry Ct Portage MI 49024-0718 Ph: (269) 323-1527 | Kalamazoo Oral & Maxillofacial Surgery, P.c. 3801 Glenkerry Ct Portage MI 49024-0718 Ph: (269) 323-1527 |
| NPI Number | 1265522262 |
|---|---|
| Provider Enumeration Date | 10/13/2006 |
| Last Update Date | 06/02/2015 |
| Medicare PECOS PAC ID | 5092994384 |
|---|---|
| Medicare Enrollment ID | O20110119000228 |
News Archive
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
The PhytoLabs group of companies, holder of the world wide rights to the newly released University of Mississippi's immuno-stimulatory dietary supplement, is very pleased to announce that Patent #7,205,284 for Potent Immunostimulants from Microalgae has been issued by the U.S. Patent and Trademark Office (USPTO).
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
The California Institute for Regenerative Medicine - which is in charge of implementing the 10-year, $2.95 billion state human embryonic stem cell research program approved under Proposition 71 - on Wednesday released a draft spending plan that "sets a strikingly modest tone" for outcomes of the research.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265522262 | NPI | - | NPPES |
| 1669433793 | Other | TYPE 1 NPI T. SLACK | |
| 1376705038 | Other | TYPE 1 NPI D. WILSON | |
| 1164416194 | Other | TYPE 1 NPI K. MORSE | |
| 1952361594 | Other | TYPE 1 NPI C. KANAR | |
| 1780645804 | Other | TYPE 1 NPI J. GISSAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223S0112X | Dentist - Oral And Maxillofacial Surgery | (* (Not Available)) | Primary |
| Provider Name | Kevin D Morse |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1164416194 PECOS PAC ID: 1658550975 Enrollment ID: I20110119000456 |
News Archive
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
The PhytoLabs group of companies, holder of the world wide rights to the newly released University of Mississippi's immuno-stimulatory dietary supplement, is very pleased to announce that Patent #7,205,284 for Potent Immunostimulants from Microalgae has been issued by the U.S. Patent and Trademark Office (USPTO).
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
The California Institute for Regenerative Medicine - which is in charge of implementing the 10-year, $2.95 billion state human embryonic stem cell research program approved under Proposition 71 - on Wednesday released a draft spending plan that "sets a strikingly modest tone" for outcomes of the research.
› Verified 3 days ago
| Provider Name | Christian L Kanar |
|---|---|
| Provider Type | Practitioner - Maxillofacial Surgery |
| Provider Identifiers | NPI Number: 1952361594 PECOS PAC ID: 0749469047 Enrollment ID: I20110121000520 |
News Archive
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
The PhytoLabs group of companies, holder of the world wide rights to the newly released University of Mississippi's immuno-stimulatory dietary supplement, is very pleased to announce that Patent #7,205,284 for Potent Immunostimulants from Microalgae has been issued by the U.S. Patent and Trademark Office (USPTO).
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
The California Institute for Regenerative Medicine - which is in charge of implementing the 10-year, $2.95 billion state human embryonic stem cell research program approved under Proposition 71 - on Wednesday released a draft spending plan that "sets a strikingly modest tone" for outcomes of the research.
› Verified 3 days ago
| Provider Name | David Wilson |
|---|---|
| Provider Type | Practitioner - Maxillofacial Surgery |
| Provider Identifiers | NPI Number: 1376705038 PECOS PAC ID: 0042525271 Enrollment ID: I20150818004444 |
News Archive
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
The PhytoLabs group of companies, holder of the world wide rights to the newly released University of Mississippi's immuno-stimulatory dietary supplement, is very pleased to announce that Patent #7,205,284 for Potent Immunostimulants from Microalgae has been issued by the U.S. Patent and Trademark Office (USPTO).
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
The California Institute for Regenerative Medicine - which is in charge of implementing the 10-year, $2.95 billion state human embryonic stem cell research program approved under Proposition 71 - on Wednesday released a draft spending plan that "sets a strikingly modest tone" for outcomes of the research.
› Verified 3 days ago
| Provider Name | Eric Thomas Safranski |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1992151682 PECOS PAC ID: 9032401864 Enrollment ID: I20200714000520 |
News Archive
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
The PhytoLabs group of companies, holder of the world wide rights to the newly released University of Mississippi's immuno-stimulatory dietary supplement, is very pleased to announce that Patent #7,205,284 for Potent Immunostimulants from Microalgae has been issued by the U.S. Patent and Trademark Office (USPTO).
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
The California Institute for Regenerative Medicine - which is in charge of implementing the 10-year, $2.95 billion state human embryonic stem cell research program approved under Proposition 71 - on Wednesday released a draft spending plan that "sets a strikingly modest tone" for outcomes of the research.
› Verified 3 days ago
| Provider Name | Michael Jeffrey Harrison |
|---|---|
| Provider Type | Practitioner - Oral Surgery |
| Provider Identifiers | NPI Number: 1972006914 PECOS PAC ID: 6103175807 Enrollment ID: I20221004003027 |
News Archive
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
The PhytoLabs group of companies, holder of the world wide rights to the newly released University of Mississippi's immuno-stimulatory dietary supplement, is very pleased to announce that Patent #7,205,284 for Potent Immunostimulants from Microalgae has been issued by the U.S. Patent and Trademark Office (USPTO).
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
The California Institute for Regenerative Medicine - which is in charge of implementing the 10-year, $2.95 billion state human embryonic stem cell research program approved under Proposition 71 - on Wednesday released a draft spending plan that "sets a strikingly modest tone" for outcomes of the research.
› Verified 3 days ago
News Archive
Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL).
The PhytoLabs group of companies, holder of the world wide rights to the newly released University of Mississippi's immuno-stimulatory dietary supplement, is very pleased to announce that Patent #7,205,284 for Potent Immunostimulants from Microalgae has been issued by the U.S. Patent and Trademark Office (USPTO).
Allopurinol, a relatively inexpensive anti-gout medication that has been on the market for more than 20 years, may have some activity against colorectal adenomas, according to data presented at the Ninth Annual AACR Frontiers in Cancer Prevention Research Conference, held here Nov. 7-10, 2010.
The California Institute for Regenerative Medicine - which is in charge of implementing the 10-year, $2.95 billion state human embryonic stem cell research program approved under Proposition 71 - on Wednesday released a draft spending plan that "sets a strikingly modest tone" for outcomes of the research.
› Verified 3 days ago
Centre Dental Associates, P.c. Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 621 W Centre Ave, Portage, MI 49024 Phone: 269-323-3128 Fax: 269-323-2005 | |
Johnson Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1617 E Milham Ave, Portage, MI 49002 Phone: 269-381-7250 Fax: 269-381-7260 | |
Dental Dreams Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5200 S Westnedge Ave, Portage, MI 49002 Phone: 269-382-6656 | |
Scott Ellard Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5835 Oakland Drive, Portage, MI 49024 Phone: 269-329-1880 Fax: 269-329-1886 | |
Pei Wei Linda Lin Dmd Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 6714 S Westnedge Ave, Portage, MI 49002 Phone: 269-329-7900 Fax: 269-329-1372 | |
Dan J Vandermeulen Dds Ms & Ronald W Reoch Dds Ms Pc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 8191 Moorsbridge Rd, Ste A, Portage, MI 49024 Phone: 269-323-1022 Fax: 269-323-0702 | |
West Wind Family &cosmetic Denistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 1617 E Milham Ave, Portage, MI 49002 Phone: 269-381-7770 Fax: 269-381-7790 |